Myocardial Effects of IMVAMUNE

Abstract

Get full access to this article

View all access options for this article.

References

Fulginiti

, Papier

, Lane

, et al. Smallpox vaccination: a review, part II. Adverse events. Clin Infect Dis, 2003; 37:251-271.

Yamaguchi

, Kimura

, Hirayama

. Report of the National Smallpox Vaccination Research Committee: study of side effects, complications and their treatments [in Japanese]. Clin Virol, 1975; 3:269-278.

Neff

, Modlin

, Birkhead

, et al. Monitoring the safety of a smallpox vaccination program in the United States: report of the joint Smallpox Vaccine Safety Working Group of the advisory committee on immunization practices and the Armed Forces Epidemiological Board. Clin Infect Dis, 2008; 46(Suppl 3):258-270.

Sniadack

, Neff

, Swerdlow

, et al. Follow-up of cardiovascular adverse events after smallpox vaccination among civilians in the United States, 2003. Clin Infect Dis, 2008; 46(Suppl 3):251-257.

ACAM2000 Package Insert, 2009. http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm180810.htm. Accessed May 9, 2014.

Elizaga

, Vasan

, Marovich

, et al. Prospective surveillance for cardiac adverse events in healthy adults receiving modified vaccinia Ankara vaccines: a systematic review. PLoS One, 2013; 8(1):e54407.